{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:12:27Z","timestamp":1791947547615,"version":"4.3.4"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA236229"],"award-info":[{"award-number":["CA236229"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA236229"],"award-info":[{"award-number":["CA236229"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Chronic graft-versus-host disease (GVHD) is an immune-mediated disorder that causes significant late morbidity and mortality following allogeneic hematopoietic cell transplantation. The \u201cClose Assessment and Testing for Chronic GVHD (CATCH)\u201d study is a multi-center Chronic GVHD Consortium prospective, longitudinal cohort study designed to enroll patients before hematopoietic cell transplantation and follow them closely to capture the development of chronic GVHD and to identify clinical and biologic biomarkers of chronic GVHD onset. Data are collected pre-transplant and every two months through one-year post-transplant with chart review thereafter. Evaluations include clinician assessment of chronic GVHD and its manifestations, patient-reported outcomes, multiple biospecimens (blood, saliva, tears, buccal mucosa and fecal samples, biopsies of skin and mouth), laboratory testing, and medical record abstraction. This report describes the rationale, design, and methods of the CATCH study, and invites collaboration with other investigators to leverage this resource.<\/jats:p>\n<jats:p><jats:bold>trial registration<\/jats:bold>: This study is registered at <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.clinicaltrials.gov\/\" xlink:type=\"simple\">www.clinicaltrials.gov<\/jats:ext-link> as <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04188912\" xlink:type=\"simple\">NCT04188912<\/jats:ext-link>.<\/jats:p>","DOI":"10.1371\/journal.pone.0298026","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T17:29:00Z","timestamp":1715880540000},"page":"e0298026","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Study protocol: Close Assessment and Testing for Chronic Graft-vs.-Host disease (CATCH)"],"prefix":"10.1371","volume":"19","author":[{"given":"Joseph","family":"Pidala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Onstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Z.","family":"Pavletic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty K.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George L.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosha","family":"Farhadfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6150-9801","authenticated-orcid":true,"given":"Marcie","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,5,16]]},"reference":[{"issue":"1","key":"pone.0298026.ref001","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood-2016-07-686642","article-title":"Classification systems for chronic graft-versus-host disease","volume":"129","author":"SJ Lee","year":"2017","journal-title":"Blood"},{"issue":"10","key":"pone.0298026.ref002","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jtct.2022.07.013","article-title":"Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis.","volume":"28","author":"RM Saliba","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"25","key":"pone.0298026.ref003","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis","volume":"388","author":"J Bolanos-Meade","year":"2023","journal-title":"N Engl J Med"},{"issue":"17","key":"pone.0298026.ref004","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1182\/blood-2010-11-319509","article-title":"Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium","volume":"117","author":"J Pidala","year":"2011","journal-title":"Blood"},{"issue":"12","key":"pone.0298026.ref005","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jamaoncol.2016.2520","article-title":"Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial.","volume":"2","author":"SJ Lee","year":"2016","journal-title":"JAMA Oncol"},{"issue":"9","key":"pone.0298026.ref006","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.3324\/haematol.2018.192930","article-title":"Patient-reported outcomes and health status associated with chronic graft-versus-host disease","volume":"103","author":"SJ Lee","year":"2018","journal-title":"Haematologica"},{"issue":"3","key":"pone.0298026.ref007","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.bbmt.2017.10.042","article-title":"Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease.","volume":"24","author":"SJ Lee","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"pone.0298026.ref008","article-title":"Durable discontinuation of systemic therapy in patients affected by chronic graft versus host disease","author":"GL Chen","year":"2022","journal-title":"Haematologica"},{"issue":"2","key":"pone.0298026.ref009","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood-2011-01-330217","article-title":"Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation","volume":"118","author":"Y Inamoto","year":"2011","journal-title":"Blood"},{"issue":"11","key":"pone.0298026.ref010","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1182\/blood.2021014448","article-title":"Three US Food and Drug Administration-approved therapies for chronic GVHD","volume":"139","author":"R Zeiser","year":"2022","journal-title":"Blood"},{"issue":"15","key":"pone.0298026.ref011","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1182\/blood-2012-09-455063","article-title":"How I assess comorbidities before hematopoietic cell transplantation","volume":"121","author":"ML Sorror","year":"2013","journal-title":"Blood"},{"issue":"3","key":"pone.0298026.ref012","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.","volume":"21","author":"MH Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"issue":"6","key":"pone.0298026.ref013","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.bbmt.2015.02.025","article-title":"Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report.","volume":"21","author":"SJ Lee","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"issue":"5","key":"pone.0298026.ref014","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.bbmt.2015.01.003","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.","volume":"21","author":"S Paczesny","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"issue":"8","key":"pone.0298026.ref015","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1053\/bbmt.2002.v8.pm12234170","article-title":"Development and validation of a scale to measure symptoms of chronic graft-versus-host disease","volume":"8","author":"S Lee","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"pone.0298026.ref016","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.bbmt.2015.12.026","article-title":"Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews.","volume":"22","author":"EC Merkel","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"pone.0298026.ref017","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bbmt.2019.11.020","article-title":"Reliability and Validity of the Modified 7-Day Lee Chronic Graft-versus-Host Disease Symptom Scale.","volume":"26","author":"C Teh","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"pone.0298026.ref018","author":"PROMIS","year":"2015","journal-title":"Dynamic Tools to Measure Health Outcomes from the Patient Perspective"},{"issue":"1","key":"pone.0298026.ref019","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-0528.1998.tb02084.x","article-title":"Assessing change in quality of life using the Oral Health Impact Profile.","volume":"26","author":"GD Slade","year":"1998","journal-title":"Community dentistry and oral epidemiology."},{"issue":"8","key":"pone.0298026.ref020","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","article-title":"Validity and Reliability of the US National Cancer Institute\u2019s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).","volume":"1","author":"AC Dueck","year":"2015","journal-title":"JAMA Oncol."},{"issue":"9","key":"pone.0298026.ref021","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju244","article-title":"Development of the National Cancer Institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).","volume":"106","author":"E Basch","year":"2014","journal-title":"J Natl Cancer Inst"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0298026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T17:29:17Z","timestamp":1715880557000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0298026"}},"subtitle":[],"editor":[{"given":"Miquel","family":"Vall-llosera Camps","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0298026","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,16]]}}}